Home › Follicular Lymphoma
Follicular Lymphoma clinical trials recruiting in the U.S.
106 studies for Follicular Lymphoma are recruiting participants at sites across the United States.
Cities with the most studies
- New York City, NY24 studies
- Houston, TX20 studies
- Milwaukee, WI19 studies
- Nashville, TN18 studies
- Baldwin Park, CA16 studies
- Seattle, WA16 studies
- Boston, MA16 studies
- Durham, NC16 studies
- Salt Lake City, UT13 studies
- Columbus, OH13 studies
- Los Angeles, CA13 studies
- Chicago, IL12 studies
- San Antonio, TX12 studies
- Philadelphia, PA12 studies
- Denver, CO11 studies
- Cleveland, OH11 studies
- Dallas, TX11 studies
- Edison, NJ11 studies
- Washington, DC11 studies
- Atlanta, GA11 studies
- Jacksonville, FL10 studies
- Rochester, MN10 studies
- Portland, OR9 studies
- New Haven, CT9 studies
- Cincinnati, OH9 studies
- Tampa, FL8 studies
- Pittsburgh, PA8 studies
- San Diego, CA8 studies
- Miami, FL8 studies
- San Francisco, CA8 studies
- Charlotte, NC7 studies
- Mountain View, CA7 studies
- Queens, NY7 studies
- Clifton, NJ7 studies
- Cedar Rapids, IA7 studies
- Austin, TX6 studies
- Richmond, VA6 studies
- Greenburgh, NY6 studies
- St. Louis, MO6 studies
- Winston-Salem, NC6 studies
By state
- Alabama5 studies
- Arizona12 studies
- Arkansas3 studies
- California36 studies
- Colorado15 studies
- Connecticut10 studies
- Delaware4 studies
- District of Columbia4 studies
- Florida25 studies
- Georgia15 studies
- Illinois14 studies
- Indiana7 studies
- Iowa9 studies
- Kansas7 studies
- Kentucky10 studies
- Louisiana8 studies
- Maryland9 studies
- Massachusetts19 studies
- Michigan12 studies
- Minnesota17 studies
- Mississippi4 studies
- Missouri8 studies
- Nebraska4 studies
- New Jersey15 studies
- New Mexico3 studies
- New York30 studies
- North Carolina25 studies
- Ohio25 studies
- Oklahoma4 studies
- Oregon11 studies
- Pennsylvania17 studies
- Rhode Island4 studies
- South Carolina6 studies
- Tennessee19 studies
- Texas37 studies
- Utah13 studies
- Virginia11 studies
- Washington20 studies
- Wisconsin21 studies
Recently updated studies
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07519772A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT03460977A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07634471A Phase 2 Study of Epcoritamab in Patients With Follicular Lymphoma and Marginal Zone Lymphoma Not Accomplishing a Complete Response With Upfront Therapy
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT06510361A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT06091254A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT06149286Clonal Evolution in Follicular Lymphoma
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT03190928A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07101328Auto Stem Cell Transplant for Lymphoma Patients
RecruitingPhase 2
Up to age 75 · All sexes · Updated Nov 4, 2026 · NCT03125642A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07226843Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 3, 2026 · NCT07215910rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder
Recruiting
Ages 22 to 65 · All sexes · Updated Nov 2, 2026 · NCT05974202A Study of ARC-02 in B-cell NHL
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT07691606Optimizing Preeclampsia Postpartum With Point-of-care Ultrasound
RecruitingPhase 4
Ages 18 and older · Women · Updated Nov 2, 2026 · NCT07167862A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
RecruitingPhase 1
Ages 4 and older · All sexes · Updated Oct 30, 2026 · NCT04573140Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RecruitingObservational study
Ages 0 to 38 · All sexes · Updated Oct 29, 2026 · NCT06131801A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT05765812Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RecruitingObservational study
Ages 18 to 120 · All sexes · Updated Oct 28, 2026 · NCT01137643Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT06108232Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RecruitingPhase 1/2
Ages 13 to 90 · All sexes · Updated Oct 26, 2026 · NCT06533579A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT07029217Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT04545762Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL
RecruitingPhase 2
Ages 3 to 31 · All sexes · Updated Oct 23, 2026 · NCT02393157A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 85 · All sexes · Updated Oct 22, 2026 · NCT07546760Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT06815029From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.